Trial Profile
Contribution of early administration of GH to the regeneration and beneficial remodeling of the left ventricle in patients with acute myocardial infarction [Contribucion de la administracion precoz de GH a la regeneracion y remodelado favorable del miocardio ventricular izquierdo en pacientes con infarto agudo de miocardio]
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 02 Apr 2012
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Myocardial infarction
- Focus Pharmacodynamics; Pharmacogenomic
- Acronyms REGENERA
- 02 Apr 2012 Planned End Date changed to 12 Aug 2011.
- 28 Jun 2011 New trial record